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The Bt Brinjal Case: The First Legal Action Against
Monsanto and Its Indian Collaborators for Biopiracy
By WALID ABDELGAWAD*
In an unprecedented case, the National Biodiversity
Authority of India (NBA), a statutory body set up
under the Biological Diversity Act 2002 (available at
http://www.genecampaign.org/home/Biological%20
Diversity%20Act%202002.pdf) to regulate access to
and use of biological resources, decided to initiate a
legal action for biopiracy against the U.S. transna-
tional seed company Monsanto and its Indian collab-
orators. The aim of these proceedings was to denounce
the use by these entities of indigenous varieties of brin-
jal to develop their genetically modified eggplant spe-
cies, Bt Brinjal, without prior authorization.
‘‘B iopiracy’’ generally refers to illegal ap-propriation of biological diversity and the
traditional knowledge of local communities from de-
veloping countries by multinational corporations and re-
search institutions.1 This definition mainly takes two
shapes: (1) access and use of biological material or tradi-
tional knowledgewithout the authorization of the country
of origin and indigenous communities that hold and de-
velop these resources; and/or (2) lack of benefit sharing,
or unjust and unfair sharing of benefits, with the countries
and communities who provided resources. These forms
of biopiracy are expressly prohibited by Articles 15 and
8(j) of the Convention of Biological Diversity (CBD)
19922 and, more recently, the Nagoya Protocol on access
and benefit sharing adopted by the Conference of the Par-
ties to the CBD at its tenth meeting on 29 October 2010.3
At the national level, many developing countries have
adopted national legislation regulating access to their ge-
netic resources and requiring benefit sharing in accor-
dance with the principles of the CBD such as, for
example, the Biological Diversity Act, 2002 in India.4
India, a country of vast biodiversity areas, is one of the
ten megadiverse countries of the world, accounting for
7.8% of the global recorded species.5
In the last decades, famous biopiracy cases concerned
disputed American or European patents granted for In-
dian plants and traditional knowledge: Curcuma, Neem,
and Basmati Rice.6 Unlike these examples, in the current
Bt brinjal case, foreign and Indian corporations and uni-
versities have been for the first time accused of biopir-
acy for violating the Biological Diversity Act in India.
After explaining framework in the Bt brinjal case,
this paper analyzes the legal allegations related to the
violations of the Biological Diversity Act by Monsanto
*Lecturer at Burgundy University (France), CREDESPO.
1See generally Vandana Shiva (1997), Biopiracy, The Plunder
of Nature and Knowledge, South End Press, Cambridge; Ikechi
Mgbeoji (2006), Global Biopiracy: Patents, Plants, and Indig-
enous Knowledge, University of British Columbia, UBC Press,
Vancouver-Toronto, Law and Society Series; Surender Singh
Chauhan (2001), Biodiversity, Biopiracy and Biopolitics: The
Global Perspective, Kalinga Publications, Delhi; Lakshmi
Sarma, Biopiracy: Twentieth Century imperialism in the form
of international agreements, 13 Temp. Int’l & Comp. L. J. 107
(1999); Lorna Dwyer, Biopiracy, trade, and sustainable develop-
ment, 19 Colo. J. Int’l Envtl. L. & Pol’y 219 (2008); see gener-
ally Walid Abdegawad, La biopiraterie et le commerce des
produits pharmaceutiques face aux droits des populations locales
sur leurs savoirs traditionnels, in Le Me´dicament et la Personne:
Aspects de Droit International, I. Moine-Dupuis (dir.), Litec,
Paris, 2007, at 323; Walid Abdelgawad, Les contrats internatio-
naux de bioprospection: moyen de protection de la biodiversite´ et
des savoirs traditionnels ou instruments de biopiraterie, 22-1
Revue Que´be´coise de droit international 53 (2009).
2Convention on Biological Diversity; available atwww.cbd.int/
doc/legal/cbd-en.pdf
3Nagoya Protocol; available at www.cbd.int/abs/doc/protocol/
nagoya-protocol-en.pdf
4The text of the Biological Diversity Act 2002 is published in
The Gazette of India, Part II Section 1, February 5, 2003.
5Indian National Biodiversity Authority website (www.nbaindia
.org/introduction.htm). For more details, see Surender Singh
Chauhan, supra n. 1 at 33.
6Many studies deal with these biopiracy cases, Vandana Shiva,
supra n. 1 at 69; Ikechi. Mgbeoji, supra n. 1 at 15 and 147;
Surender Singh Chauhan, supra n. 1 at 228; Lorna Dwyer,
supra n. 1 at 227; Walid Abdegawad (la biopiraterie), supra
n. 1 at 335; Shayana Kadidal, Subject-matter imperialism? Bio-
diversity, foreign prior art and the neem patent controversy, 37
J.L. & Tech. 371 (1997); Fritz Dolder, Traditional knowledge
and patenting: the experience of the neem fungicide and the
hoodia cases, 26 Biotechnol. L. Rep. 583 (2007).
31 Biotechnology Law Report 136
Number 2, 2012
# Mary Ann Liebert, Inc.
DOI: 10.1089/blr.2012.9926
136
and its Indian collaborators and the impact of a poten-
tial judicial condemnation of Bt Brinjal developers.
ESTABLISHING THE FRAMEWORK
OF THE BT BRINJAL CASE
In its resolution adopted on 20 June 2011,7 the
National Biodiversity Authority of India (NBA) de-
cided to ‘‘proceed legally’’ against Monsanto, its In-
dian partner Maharashtra Hybrid Seeds Company
(Mahyco)—26% of which is owned by Monsanto—
and their Indian collaborators, the University of Agri-
culture Sciences (UAS) at Dharwad in north Karnataka
(hereinafter UAS-Dharwad) and Sathguru Management
Consultants Ltd, a private Indian company acting as a
coordinator on behalf of USAID and Cornell Univer-
sity. The NBA’s decision challenges the Indian legal
system, because it will highlight the manner in which
courts will interpret and implement the Biological
Diversity Act in an area of growing concern. This bio-
piracy case is related to an important and sensitive field
which threatens both material and spiritual interests of
the local communities and farmers who are the holders
of traditional knowledge on biological resources.
Brinjal, which is the Indian name of eggplant, has
been cultivated in India by millions of farmers, who
have developed 2,500 varieties. This plant, popular
in Indian recipes, is also used as a religious offering
in some areas of India.
The NBA decision charges these three entities with
alleged violation of the Biological Diversity Act, ‘‘for
accessing and using the local brinjal varieties for devel-
opment of Bt brinjal without prior approval of the
competent authorities (.).’’8 According to the NBA
secretary, ‘‘The authority has decided to proceed legally
against Mahyco and Monsanto, and all other concerned
to take the issue to its logical conclusion’’9; conse-
quently, Bt brinjal developers could face ‘‘criminal pro-
ceedings’’ for violation of the Biological Diversity Act,
2002.10 Recently, this decision was formally confirmed
by NBA during its meeting held in NewDelhi in August
2011. As an NBA senior official stated, ‘‘The NBA is
now continuously moving forward in that direction.’’11
The NBA decision originated with a complaint
(available at www.esgindia.org/campaigns/brinjal/
press/national-biodiversity-authority-prosecut.html)
lodged by the Environment Support Group (ESG), a
nongovernmental organization based in Bangalore,
before the Karnataka Biodiversity Board on 15 Febru-
ary 2010. The Group had gathered and published
many official documents regarding this case on its
website.12 After investigating the file, the Karnataka
Biodiversity Board informed NBA on 28 May 2011
that, ‘‘six local varieties for development of Bt brinjal
were accessed in the state by the two companies with-
out prior approval from State Biodiversity Board/
National Biodiversity Authority’’13 and called for legal
action. The Indian farmers’ growing protests against
Bt brinjal had encouraged the Minister of Environment
to announce on February 2010, just before the ESG’s
complaint, a moratorium on Bt brinjal until there is a
public consensus on health and safety issues.14
The crux of the matter in this case is a ‘‘sublicense
agreement’’15 (available atwww.esgindia.org/campaigns/
brinjal/press/national-biodiversity-authority-prosecut
.html), dated 23 April 2005, in force between the three
parties: Mahyco, UAS-Dharwad, and Sathguru. This
tripartite agreement recited a common objective in
development and delivery ‘‘of pro-poor varieties of in-
sect tolerant Bt. eggplant’’16—that is, genetically mod-
ified Bt brinjal. This transfer technology agreement was
part of a U.S.–Indian public–private partnership, pro-
moted by USAID and managed by Cornell University.
This consortium, whose Indian coordinator is Sathguru,
is intended to facilitate the development of bioengi-
neered products in developing countries under the Agri-
culture Biotechnology Support Project II (ABSP-II).
In accordance with this agreement, Mahyco trans-
ferred the Cry1AC gene technology (supplied by
Monsanto) to the six local varieties provided by
UAS-Dharwad by backcrossing. This technology
was transferred by Mahyco to UAS (and also to the
Tamil Nadu Agriculture University) as a royalty-free
license to make it available ‘‘to resource-constrained
farmers under the ABSPII project’’17 in India.
THE LEGAL ALLEGATIONS REGARDING
VIOLATION OF THE BIOLOGICAL
DIVERSITY ACT, 2002
In its complaint before the Karnataka Biodiversity
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allegations of violations of the Biological Diversity
Act by the contracting parties.
The first allegation is related to the violation of Sec-
tions 3 and 4 of the Act. Section 3 requires foreign
companies or citizens who seek access to biological
resources to obtain the prior approval of the NBA.
The same requirement is stated in Section 4, in the
case of a transfer of any research result related to bio-
logical resources to foreign companies or citizens. An
exemption is provided by Section 5 (1), which holds
that the prior approval of NBA is not required in the
case of a ‘‘collaborative research project’’ involving
Indian and foreign institutions under the conditions
that such project (1) ‘‘be approved by the Central Gov-
ernment,’’ and ii) ’’conform[] to the policy guidelines
issued by the Central Government.’’19 These Guide-
lines were published by the Ministry of Environment
and Forests in November 2006.20
After examining the subject matter, the NBA con-
cluded that ‘‘the said research project seems prima
facie to fall outside the scope of guidelines issued by
the Central Government.’’21 As a result, the three par-
ties of the sublicense agreement had no right to an ex-
emption under Section 5 (1), and thus should have
obtained NBA approval. NBA expressly noted that it
‘‘has not received any application from any of the par-
ties’’22 under Sections 3 or 4. This first allegation
based on the violation of Sections 3 and 4 seems to
be the most convincing argument.
Second, ESG accused the contracting parties of fail-
ing to give prior notice to the Karnataka Biodiversity
Board (KBB); this is mandatory under Section 7 in
order to get biological resources ‘‘for commercial utili-
zation.’’ This allegation is relevant only if there is
‘‘commercial utilization’’ of Bt eggplant technology,
which may not be the case for this sublicense agree-
ment, which prima facie aims to transfer technology
to UAS-Dharwad without commercial uses. This agree-
ment provided that Mahyco, as a sublicensor, ‘‘. has
agreed to provide access to the technology without
any payment for such access.’’23 It grants to UAS-Dhar-
wad ‘‘. a royalty-fee, not-for-profit sublicense’’24 so as
to develop or distribute to resource-constrained farmers
‘‘other than by sale’’ licensed domestic eggplant prod-
ucts. Thus, the sublicense agreement does not provide
for commercial utilization of Bt eggplant technology.
However, this agreement has to be examined in the
light of two factors. First, the disputed agreement is
part of the ABSP II Project, which is defined as a pro-
ject that focuses ‘‘on the safe and effective develop-
ment and commercialization of bio-engineered
products.in developing countries..’’25 Second, as
expressly mentioned in the sublicense agreement,
Mahyco previously entered into agreement with Sath-
guru on 10 March 2005 the aim of which was to under-
take the research and development of varieties of
eggplant tolerant to fruit and shoot borer, ‘‘with a
view to product commercialization or other distribu-
tion in certain South-Asian and East Asian territories
by Licensed ABSP II collaborators.’’26 These two as-
pects throw doubt on the real intention of the three
parties to the disputed sublicense arrangement. For
these reasons, further investigations must be launched
to ascertain whether the Bt brinjal has been com-
mercialized ‘‘in any manner’’27 by the parties when
implementing the sublicense agreement. Additional
information has been sought from the parties involved
in the development of Bt brinjal, and appropriate ac-
tion will be taken on the basis of this information, as
was recently confirmed by the Minister of State for
Environment and Forests, Ms. Jayanthi Natarajan, on
28 November 2011.28
The third allegation is based on the violation of Sec-
tion 41 (2), which provides that NBA and the State Bio-
diversity Board consult the Biodiversity Management
Committee, the local biodiversity authority, ‘‘while tak-
ing any decision relating to the use of biological re-
source and knowledge associated with such resources
occurring within the territorial jurisdiction of the Biodi-
versity Management Committee.’’ This allegation is
weak, however, for the reason that only the NBA and
the State Biodiversity Board (KBB) are appointed
under Section 41 (2) to consult the Biodiversity Man-
agement Committee—the three contracting parties in
this case are not directly linked to this rule.
Fourth, it is alleged that the contracting parties, ac-
cused of having access to six local varieties of brinjal
without the permission of the competent authorities,
deprived the local communities of their right (recog-
nized by the Biological Diversity Act) to equitable
benefit sharing arising out of commercial use of
these resources. This allegation is linked to the first
one and requires that there be a prior violation of the
rule related to the formal permission.
The three contracting parties’ replies to these alle-
gations were not convincing and seem to rely on a
questionable legal basis. When contacted by the
media, Monsanto denied the charges and argued that
19Section 5.3 of the Biological Diversity Act.
20These guidelines were published in The Gazette of India, Part
II, Section 3, Sub-section (ii), 8 November 2006.
21Letter from NBA to Shri. H.S. Sugara IFS, Member Secretary
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it had not developed Bt brinjal but that it had been ‘‘de-
veloped by Mahyco, with Cry1AC gene accessed from
Monsanto, in collaboration with multiple public sector
institutions,’’29 such as AUS-Dharwad. This argument
is weak, as Monsanto owns 26% of Mahyco’s shares;
in addition, both corporations are part of the joint ven-
ture, Mahyco Monsanto Biotech Limited, a company
that introduced Monsanto’s genetically modified cot-
ton, Bt cotton, to India. It is also relevant that Mahyco
and Monsanto are involved in the previously men-
tioned U.S.–Indian project (ABSP-II).
While disapproving of any violation of Biological
Diversity Act, Mahyco30 claimed that UAS-Dharwad
first initiated contact with Mahyco and provided it
with the local varieties of brinjal to develop Bt brinjal,
and that Mahyco merely introgressed the Cry1AC gene
into these varieties. Mahyco (supported by Sathguru31)
also argued that it does not share any royalty fee when
transferring this technology to UAS-Dharwad; more-
over, Mahyco holds the view that the sublicense agree-
ment does not stipulate any commercial use of gene
technology provided by Mahyco to UAS-Dharwad.32
In its letter dated 25 April 2011,33 NBA observed that
if the Bt gene was transferred by Mahyco to UAS
after incorporating the Cry1AC gene into the local vari-
ety of brinjal, Mahyco would infringe Section 3 of the
Act, which requires prior approval. More information
is needed from the parties to clarify this issue.
Lastly, UAS-Dharwad34 claimed that ABSPII pro-
ject was initiated with—and approved by—the
Department of Biotechnology, the Ministry of Science
and Technology of the Government of India. It cited a
list of permissions obtained from various competent
Indian authorities. It is doubtful, however, that such
permissions will fulfill the requirements of the Biolog-
ical Diversity Act, which expressly designates NBA,
the Karnataka Biodiversity Board, and the Biodiver-
sity Management Committees as the competent au-
thorities for access to and use of biodiversity
resources in India. UAS-Dharwad has not mentioned
any permission provided by these three bodies.
WHAT MIGHT BE THE IMPACT
OF THE BT BRINJAL CASE?
The potential condemnation for biopiracy in the Bt
brinjal case could undermine Monsanto’s other request
to access two varieties of Indian onion for potential
hybridization, which is now under examination by
the authorities. More broadly, it could threaten the de-
velopment of Monsanto’s hybrids seeds and geneti-
cally modified crops in India. It is relevant to refer
to the current project, supported by the U.S. govern-
ment, to introduce Nepal hybrid maize seeds produced
by Monsanto. Protesters denounced this project as an
attempt to conceal Monsanto’s long-term plan to intro-
duce its transgenic maize in Nepal.35 Another project
threatened by the NBA decision is the current Mahyco
plan to introduce Bt rice for commercial production.
Even the only authorized Monsanto genetically
modified crop in India, Bt cotton, which contains the
same gene (Cry1AC) as the Bt brinjal, is now subject
to restrictive measures. In fact, India has produced Bt
cotton widely for the past 10 years, but recently, an in-
creasing number of States have changed their attitude
toward this kind of seed. The government of the
Tamil Nadu announced last August 2011 it would not
promote Bt cotton, and seven Indian states have already
declared themselves free from transgenic crop trials.36
These measures were adopted after farmers’ organiza-
tions and activists demonstrated against Monsanto Bt
cotton. The demonstrators alleged that thousands of in-
debted farmers had committed suicide, victims of in-
creasing quantities of inputs and facing higher prices
for Bt cotton after the withholding of stocks from the
market, in particular in Andhra Pradesh.37 The outcome
of the Bt binjab case could also reinforce the develop-
ment of alternatives to Monsanto’s Bt genes, such as
might come from enhanced funding of public agricul-
ture research and increased utilization of the traditional
knowledge of local communities.
By adopting this decision, for the first time, the
NBA aims to issue a firm message to foreign agencies
and their Indians collaborators: from now on, the prac-
tice of biopiracy in India might be prosecuted legally.
Future developments will tell us what to expect from
this new public policy.
  
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